Last updated on November 2017

A Phase 2a, Randomized, Double-Blind, Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of XXX in Patients with Fibromyalgia


Brief description of study

A Phase 2a, Randomized, Double-Blind, Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of XXX in Patients with Fibromyalgia

Detailed Study Description

Qualifying male and female subjects between 18 and 80 years of age with fibromyalgia to help assess the Analgesic & Efficacy and Safety of the study medication.

Clinical Study Identifier: TX12811

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Columbus Regional Research Institute

Columbus Regional Research Institute
Columbus, GA USA
  Connect »